Diagnosis and treatment of heart failure in primary care: Low correlation between pro-ANF and heart failure;Diagnostik och behandling av hjärtsvikt i primärvården: Låg korrelation mellan Pro-ANF och hjärtsvikt

Lakartidningen

Volumn 97, Issue 3, 2000, Pages 159-162

  Blomqvist, Kjell ^a   Örtoft, Kjell ^a   Johansson, Åke ^a   Ascione, Salvatore ^a   Nylander, Eva ^b   Åkerlind, Ingemar ^c  

^a Åby Vård central ^*  (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^c Primärvårdens FoU enhet   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

AGED; ARTICLE; CONGESTIVE HEART FAILURE; ECHOGRAPHY; FOLLOW UP; HUMAN; METABOLISM; PRIMARY HEALTH CARE; SWEDEN;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ATRIAL NATRIURETIC FACTOR; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; PRIMARY HEALTH CARE; SWEDEN;

EID: 0034684917     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. New York Heart Association. Diseases of the heart and bloodvessels. 7th ed. Boston: Little Brown, 1973.
2. Olsson K, Karlberg BE, Eriksson L. Atrial natriuretic peptide in pregnant and lactating goats. Acta Endocrinol 1989; 120: 519-25.
3. Oh JK, Appleton CP, Hatle LK, Nishimura RA, Seward JB, Tajik AJ. The non-invasive assessment of left ventricular diastolic function with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 1997; 10: 246-70.
4. Francis CM, Caracuana L, Kearney P, Love M, Sutherland GR, Starkey IR et al. Open access echocardiography in management of heart failure in the community. BMJ 1995; 310: 634-6.
5. Cleland JGF. Diagnosis of heart failure. Heart 1998; 79: 10-6.
6. Remes J, Miettinen H, Reunanen A, Pyörälä K. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 1991; 12: 315-32.
7. Wheeldon NM, MacDonald TM, Flucker CJ, McKendrick AD, McDevitt DG, Struthers AD. Echocardiography in chronic heart failure in the community. QJM 1993; 86: 17-23.
8. Fruhwald FM, Watzinger N, Schumacher M, Zweiker R, Pokan R, Klein W. The extent of diastolic dysfunction and its correlation with subjective impairment of physical capacity in dilatated cardiomyopathy. Dtsch Med Wochenschr 1997; 122: 845-8.
9. Fagerberg B. Diastolisk dysfunktion ofta bakom hjärtsvikt hos äldre och kvinnor. Läkartidningen 1998; 95: 5305-8.
10. Clarke KW, Gray D, Hampton JR. Evidence of inadequate investigation and treatment of patients with heart failure. Br Heart J 1994; 71: 584-7.
11. Kuecherer HF, Kee LL, Modin G, Cheitlin MD, Schiller NB. Echocardiography in serial evaluation of left ventricular systolic and diastolic function: importance of image acquisition, quantitation, and physiologic variability in clinical and investigational applications. J Am Soc Echocardiogr 1991; 4: 203-14.
12. Daggubati S, Parks JR, Overton RM, Cintron G, Schocken DD, Vesley DL. Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone peptides compared as early heart failure indicators. Cardiovasc Res 1997; 36: 246-55.
13. Cowie MR, Struthers AD, Wodd DA, Coats AJ, Thompson SG, Poole Wilson PA et al. Value of natriuretic peptides in assessment of patients with possible heart failure in primary care. Lancet 1997; 350: 1349-53.
14. Arad M, Elazar E, Shotan A, Klein R, Robinowitz B. Brain and atrial natriuretic peptides in patients with ischemic heartdisease with or without heart failure. Cardiol 1996; 87: 12-7.
15. Hunt PJ, Richards AM, Nicholls MG, Yandle TG, Doughty RN, Espiner EA. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin Endocrinol (Oxf) 1997; 47: 287-96.
16. Lindstedt G, Bergh CH, Caidahl K, Ekman R, Fagerberg B, Isgaard J et al. Utredning och behandling av hjärtsvikt söker nya vägar. Läkartidningen 1998; 95: 5311-5.
17. Szucs TD, Goedde M, Berger K, Kiowski W. Cost effectiveness of ACE inhibition in therapy of chronic heart failure in Switzerland: evaluation based on the SOLVD study. Schweiz Med Wochenschr 1997; 127: 1234-41.
18. Hillis GS, Trent RJ, Winton P, MacLeod AM, Jennings KP. Angiotensin-converting-enzyme inhibitors in the management of cardiac failure: are we ignoring the evidence? QJM. 1996; 89: 145-50.
19. Israelsson B, Wroblewsk M, Ilestam G. Goda resultat av satsning på hjärtsviktsvården i Malmö. Läkartidningen 1998; 95: 2702-6.
20. Eccles M, Freemantle N, Mason J. North of England evidence based development project: guideline for angiotensin converting enzyme inhibitors in primary care management of adults with symptomatic heart failure. BMJ 1998; 316: 1369-75.